The η-class carbonic anhydrases as drug targets for antimalarial agents

Bibliography

• Jeremiah S, Janagond AB, Parija SC. Challenges in diagnosis of Plasmodium knowlesi infections. Trop Parasitol 2014;4:25-30
   PubMedGoogle Scholar
• Fan L, Lee SY, Koay E, et al. Plasmodium knowlesi infection: a diagnostic challenge. BMJ Case Rep 2013;2013 10.1136/bcr-2013-009558
   Google Scholar
• Antinori S, Galimberti L, Milazzo L, et al. Biology of human malaria plasmodia including Plasmodium knowlesi. Mediterr J Hematol Infect Dis 2012;4:e2012013 10.4084/MJHID.2012.013
   PubMedGoogle Scholar
• Burchard G. Therapeutic management of malaria. Internist (Berl) 2011;52:1407-13
   PubMed Web of Science ®Google Scholar
• Sabbatani S, Manfredi R, Fiorino S. Malaria infection and human evolution. Infez Med 2010;18:56-74
   PubMedGoogle Scholar
• Capasso C, Supuran CT. Anti-infective carbonic anhydrase inhibitors: a patent and literature review. Expert Opin Ther Pat 2013;23:693-704
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, Fisher GM, et al. Discovery of a new family of carbonic anhydrases in the malaria pathogen Plasmodium falciparum-The eta-carbonic anhydrases. Bioorg Med Chem Lett 2014;24:4389-96
   PubMed Web of Science ®Google Scholar
• Dondorp AM, Desakorn V, Pongtavornpinyo W, et al. Estimation of the total parasite biomass in acute falciparum malaria from plasma PfHRP2. PLoS Med 2005;2:e204
   PubMed Web of Science ®Google Scholar
• Miller LH, Baruch DI, Marsh K, et al. The pathogenic basis of malaria. Nature 2002;415:673-9
   PubMed Web of Science ®Google Scholar
• Storm J, Muller S. Lipoic acid metabolism of Plasmodium – a suitable drug target. Curr Pharm Des 2012;18:3480-9
   PubMed Web of Science ®Google Scholar
• Krungkrai J, Krungkrai SR, Supuran CT. Carbonic anhydrase inhibitors: inhibition of Plasmodium falciparum carbonic anhydrase with aromatic/heterocyclic sulfonamides-in vitro and in vivo studies. Bioorg Med Chem Lett 2008;18:5466-71
   PubMed Web of Science ®Google Scholar
• Krungkrai J, Scozzafava A, Reungprapavut S, et al. Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action? Bioorg Med Chem 2005;13:483-9
   PubMed Web of Science ®Google Scholar
• Gosling RD, Cairns ME, Chico RM, et al. Intermittent preventive treatment against malaria: an update. Expert Rev Anti Infect Ther 2010;8:589-606
   PubMed Web of Science ®Google Scholar
• Jirage D, Keenan SM, Waters NC. Exploring novel targets for antimalarial drug discovery: plasmodial protein kinases. Infect Disord Drug Targets 2010;10:134-46
   PubMedGoogle Scholar
• Dharia NV, Chatterjee A, Winzeler EA. Genomics and systems biology in malaria drug discovery. Curr Opin Investig Drugs 2010;11:131-8
   PubMedGoogle Scholar
• Krungkrai J, Krungkrai SR, Supuran CT. Malarial parasite carbonic anhydrase and its inhibitors. Curr Top Med Chem 2007;7:909-17
   PubMed Web of Science ®Google Scholar
• Krungkrai J, Supuran CT. The alpha-carbonic anhydrase from the malaria parasite and its inhibition. Curr Pharm Des 2008;14:631-40
   PubMed Web of Science ®Google Scholar
• Mastrolorenzo A, Rusconi S, Scozzafava A, et al. Inhibitors of HIV-1 protease: current state of the art 10 years after their introduction. From antiretroviral drugs to antifungal, antibacterial and antitumor agents based on aspartic protease inhibitors. Curr Med Chem 2007;14:2734-48
   PubMed Web of Science ®Google Scholar
• Reungprapavut S, Krungkrai SR, Krungkrai J. Plasmodium falciparum carbonic anhydrase is a possible target for malaria chemotherapy. J Enzyme Inhib Med Chem 2004;19:249-56
   PubMed Web of Science ®Google Scholar
• Sein KK, Aikawa M. The pivotal role of carbonic anhydrase in malaria infection. Med Hypotheses 1998;50:19-23
   PubMed Web of Science ®Google Scholar
• Pan P, Vermelho AB, Scozzafava A, et al. Anion inhibition studies of the alpha-carbonic anhydrase from the protozoan pathogen Trypanosoma cruzi, the causative agent of Chagas disease. Bioorg Med Chem 2013;21:4472-6
   PubMed Web of Science ®Google Scholar
• Syrjanen L, Vermelho AB, Rodrigues Ide A, et al. Cloning, characterization, and inhibition studies of a beta-carbonic anhydrase from Leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. J Med Chem 2013;56:7372-81
   PubMed Web of Science ®Google Scholar
• Akdemir A, Vullo D, De Luca V, et al. The extremo-alpha-carbonic anhydrase (CA) from Sulfurihydrogenibium azorense, the fastest CA known, is highly activated by amino acids and amines. Bioorg Med Chem Lett 2013;23:1087-90
   PubMed Web of Science ®Google Scholar
• Alafeefy AM, Abdel-Aziz HA, Vullo D, et al. Inhibition of carbonic anhydrases from the extremophilic bacteria Sulfurihydrogenibium yellostonense (SspCA) and S. azorense (SazCA) with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties. Bioorg Med Chem 2014;22:141-7
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. An overview of the alpha-, beta- and gamma-carbonic anhydrases from Bacteria: can bacterial carbonic anhydrases shed new light on evolution of bacteria? J Enzyme Inhib Med Chem 2014 10.3109/14756366.2014.910202
   Web of Science ®Google Scholar
• Ceruso M, Del Prete S, Alothman Z, et al. Sulfonamides with Potent Inhibitory Action and Selectivity against the alpha-Carbonic Anhydrase from Vibrio cholerae. ACS Med Chem Lett 2014;5:826-30
   PubMed Web of Science ®Google Scholar
• De Luca V, Vullo D, Scozzafava A, et al. Anion inhibition studies of an alpha-carbonic anhydrase from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Bioorg Med Chem Lett 2012;22:5630-4
   PubMed Web of Science ®Google Scholar
• Del Prete S, De Luca V, Scozzafava A, et al. Biochemical properties of a new alpha-carbonic anhydrase from the human pathogenic bacterium, Vibrio cholerae. J Enzyme Inhib Med Chem 2014;29:23-7
   PubMed Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. Biochemical characterization of recombinant beta-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis. J Enzyme Inhib Med Chem 2014 10.3109/14756366.2014.931383
   Web of Science ®Google Scholar
• Del Prete S, Vullo D, De Luca V, et al. A highly catalytically active gamma-carbonic anhydrase from the pathogenic anaerobe Porphyromonas gingivalis and its inhibition profile with anions and small molecules. Bioorg Med Chem Lett 2013;23:4067-71
   PubMed Web of Science ®Google Scholar
• Migliardini F, De Luca V, Carginale V, et al. Biomimetic CO2 capture using a highly thermostable bacterial alpha-carbonic anhydrase immobilized on a polyurethane foam. J Enzyme Inhib Med Chem 2014;29:146-50
   PubMed Web of Science ®Google Scholar
• Prete SD, Vullo D, Osman SM, et al. Sulfonamide inhibition study of the carbonic anhydrases from the bacterial pathogen Porphyromonas gingivalis: the beta-class (PgiCAb) versus the gamma-class (PgiCA) enzymes. Bioorg Med Chem 2014;22:4537-43
   PubMed Web of Science ®Google Scholar
• Vullo D, De Luca V, Scozzafava A, et al. Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense. Bioorg Med Chem Lett 2012;22:7142-5
   PubMed Web of Science ®Google Scholar
• Alterio V, Langella E, Viparelli F, et al. Structural and inhibition insights into carbonic anhydrase CDCA1 from the marine diatom Thalassiosira weissflogii. Biochimie 2012;94:1232-41
   PubMed Web of Science ®Google Scholar
• Viparelli F, Monti SM, De Simone G, et al. Inhibition of the R1 fragment of the cadmium-containing zeta-class carbonic anhydrase from the diatom Thalassiosira weissflogii with anions. Bioorg Med Chem Lett 2010;20:4745-8
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors. Bioorg Med Chem Lett 2010;20:3467-74
   PubMed Web of Science ®Google Scholar
• Di Fiore A, Capasso C, De Luca V, et al. X-ray structure of the first `extremo-alpha-carbonic anhydrase’, a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1. Acta Crystallogr D Biol Crystallogr 2013;69:1150-9
   PubMed Web of Science ®Google Scholar
• Capasso C, Supuran CT. Sulfa and trimethoprim-like drugs - antimetabolites acting as carbonic anhydrase, dihydropteroate synthase and dihydrofolate reductase inhibitors. J Enzyme Inhib Med Chem 2014;29:379-87
   PubMed Web of Science ®Google Scholar
• Nishimori I, Vullo D, Minakuchi T, et al. Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition. Bioorg Med Chem Lett 2013;23:256-60
   PubMed Web of Science ®Google Scholar
• Luca VD, Vullo D, Scozzafava A, et al. An alpha-carbonic anhydrase from the thermophilic bacterium Sulphurihydrogenibium azorense is the fastest enzyme known for the CO2 hydration reaction. Bioorg Med Chem 2013;21:1465-9
   PubMed Web of Science ®Google Scholar
• Carta F, Supuran CT, Scozzafava A. Sulfonamides and their isosters as carbonic anhydrase inhibitors. Future Med Chem 2014;6:1149-65
   PubMed Web of Science ®Google Scholar
• McKenna R, Supuran CT. Carbonic anhydrase inhibitors drug design. Subcell Biochem 2014;75:291-323
   PubMedGoogle Scholar
• Masini E, Carta F, Scozzafava A, et al. Antiglaucoma carbonic anhydrase inhibitors: a patent review. Expert Opin Ther Pat 2013;23:705-16
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors: an editorial. Expert Opin Ther Pat 2013;23:677-9
   PubMed Web of Science ®Google Scholar
• Carta F, Scozzafava A, Supuran CT. Sulfonamides: a patent review (2008 - 2012). Expert Opin Ther Pat 2012;22:747-58
   PubMed Web of Science ®Google Scholar
• Alterio V, Di Fiore A, D’Ambrosio K, et al. Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms? Chem Rev 2012;112:4421-68
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Med Chem 2011;3:1165-80
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168-81
   PubMed Web of Science ®Google Scholar
• Winum JY, Rami M, Scozzafava A, et al. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents. Med Res Rev 2008;28:445-63
   PubMed Web of Science ®Google Scholar
• Supuran CT. Carbonic anhydrases as drug targets–an overview. Curr Top Med Chem 2007;7:825-33
   PubMed Web of Science ®Google Scholar
• Lavigne R, Seto D, Mahadevan P, et al. Unifying classical and molecular taxonomic classification: analysis of the Podoviridae using BLASTP-based tools. Res Microbiol 2008;159:406-14
   Google Scholar
• Mount DW. Using the Basic Local Alignment Search Tool (BLAST). CSH Protoc 2007;2007:pdb top17
   PubMedGoogle Scholar
• Vullo D, Del Prete S, Fisher GM, et al. Sulfonamide inhibition studies of the eta-class carbonic anhydrase from the malaria pathogen Plasmodium falciparum. Bioorg Med Chem; submitted for publication. In press
   Web of Science ®Google Scholar
• Criscuolo A. morePhyML: improving the phylogenetic tree space exploration with PhyML 3. Mol Phylogenet Evol 2011;61:944-8
   PubMed Web of Science ®Google Scholar
• Guindon S, Dufayard JF, Lefort V, et al. New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst Biol 2010;59:307-21
   PubMed Web of Science ®Google Scholar